2238 Kaltenbach, Karol - Jefferson Medical College - Thomas Jefferson University
kxk121

Karol Kaltenbach, PhD

Contact Dr. Kaltenbach

1233 Locust Street
Suite 401
Philadelphia, PA 19107

(215) 955-4068

Most Recent Peer-reviewed Publications

  1. Induction of pregnant women onto opioid-agonist maintenance medication: An analysis of withdrawal symptoms and study retention
  2. Cigarette smoking in opioid-dependent pregnant women: Neonatal and maternal outcomes
  3. Opioid dependence during pregnancy: Relationships of anxiety and depression symptoms to treatment outcomes
  4. Buprenorphine treatment of opioid-dependent pregnant women: A comprehensive review
  5. Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication
  6. Maternal opioid treatment: Human experimental research (mother)-approach, issues and lessons learned
  7. Co-occurring psychiatric symptoms in opioid-dependent women: The prevalence of antenatal and postnatal depression
  8. Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine
  9. Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates
  10. Fetal assessment before and after dosing with buprenorphine or methadone
  11. Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication
  12. Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy
  13. Neonatal abstinence syndrome
  14. Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: Can we assure the safety of the fetus
  15. Methadone and buprenorphine for the management of opioid dependence in pregnancy
  16. Cigarette smoking and neonatal outcomes in depressed and nondepressed opioid-dependent agonist-maintained pregnant patients
  17. Methadone and perinatal outcomes: Another perspective
  18. Methadone and the causes of maternal and perinatal complications: A response to Pinto et al. "substance abuse during pregnancy: Effect on pregnancy outcomes" [Eur. J. Obstet. Gynecol. Reprod. Biol. 150 (2010) 137-141]
  19. Neonatal abstinence syndrome after methadone or buprenorphine exposure
  20. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome
0